HMGCR MRNA expression in tongue squamous cell carcinoma (2007)
- Authors:
- USP affiliated authors: FEDERICO, MIRIAM HATSUE HONDA - FM ; PASINI, FÁTIMA SOLANGE - FM
- Unidade: FM
- Subjects: EXPRESSÃO GÊNICA; PROGNÓSTICO; BIOMARCADORES; CARCINOMA DE CÉLULAS ESCAMOSAS; RESUMOS (SIMPÓSIOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio avanços em pesquisas médicas
-
ABNT
CADIMA, B. F. et al. HMGCR MRNA expression in tongue squamous cell carcinoma. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 05 out. 2024. , 2007 -
APA
Cadima, B. F., Maistro, S., Pasini, F. S., Mangone, F. R. R., Brunialti, K. C. S., Campofiorito, C. M. M., et al. (2007). HMGCR MRNA expression in tongue squamous cell carcinoma. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Cadima BF, Maistro S, Pasini FS, Mangone FRR, Brunialti KCS, Campofiorito CMM, Lenh CN, Walder F, Brentani MM, Federico MHH. HMGCR MRNA expression in tongue squamous cell carcinoma. Clinics. 2007 ; 62 S52.[citado 2024 out. 05 ] -
Vancouver
Cadima BF, Maistro S, Pasini FS, Mangone FRR, Brunialti KCS, Campofiorito CMM, Lenh CN, Walder F, Brentani MM, Federico MHH. HMGCR MRNA expression in tongue squamous cell carcinoma. Clinics. 2007 ; 62 S52.[citado 2024 out. 05 ] - Determination of plasma osteopontin levels in patients with head and neck squamous cell carcinoma
- Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT)
- New possible predictive marker of survival in oral squamous cell carcinoma
- Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients
- Gene expression pattern of primary oral cancer is predictive of cervical lymph node metastases
- Expression of CXCR1 and 'CX IND. 3'CR1 mRNA seems to outocome of the larynx squamous cell carcinoma
- Avaliação prospectiva de polimorfismo genéticos da glutationa-s-transferase P1 como fator prognóstico e preditivo de resposta em pacientes portadores de carcinoma epidermóide de cabeça e pescoço tratados com quimiorradioterapia
- ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
- Identification of polymorphisms and germline mutations in BRCA1 genes in breast cancer patients indicated for genetic test
- Expressão de G3BP2 como fator prognóstico de sobrevida em pacientes com carcinoma epidermóide de cavidade oral
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas